NYSEMKT: RGNT
Regentis Biomaterials Ltd Stock Ownership - Who owns Regentis Biomaterials?

Insider buying vs selling

Have Regentis Biomaterials Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RGNT insiders and whales buy or sell their stock.

RGNT Shareholders

What type of owners hold Regentis Biomaterials Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rosalind Advisors Inc4.86%251,510$845.07kInstitution
Warberg Asset Management LLC0.37%19,093$64.15kInstitution
Citadel Advisors LLC0.20%10,412$34.98kInstitution

1 of 1

RGNT vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RGNT5.43%0.00%
RVP7.15%92.85%Net Buying
MLSS5.75%64.37%Net Selling
ZJYL0.26%0.00%
BNGO3.33%96.67%Net SellingNet Selling

Regentis Biomaterials Stock Ownership FAQ

Who owns Regentis Biomaterials?

Regentis Biomaterials (NYSEMKT: RGNT) is owned by 5.43% institutional shareholders, 0.00% Regentis Biomaterials insiders, and 94.57% retail investors. Rosalind Advisors Inc is the largest individual Regentis Biomaterials shareholder, owning 251,510.00 shares representing 4.86% of the company. Rosalind Advisors Inc's Regentis Biomaterials shares are currently valued at $845.07k.

If you're new to stock investing, here's how to buy Regentis Biomaterials stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.